High Expression of CCL20 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Curative Resection

Ding, Xiangjiu; Wang, Kexin; Wang, Hui; Zhang, Guangyong; Liu, Yajing; Yang, Qingyun; Chen, Weijie; Hu, Sanyuan
April 2012
Journal of Gastrointestinal Surgery;Apr2012, Vol. 16 Issue 4, p828
Academic Journal
Introduction: Chemokine ligand 20 (CCL20) plays an important role in the carcinogenesis, invasion, and progression of malignancies. This study aimed to investigate the prognostic significance of CCL20 in patients with hepatocellular carcinoma (HCC) after curative resection. Methods: Expression of CCL20 was evaluated by immunohistochemistry in tumor tissue from 125 patients who underwent curative resection of HCC. The relationship between CCL20 expression and clinicopathologic features was analyzed. Univariate and multivariate analyses were performed to evaluate its predictive value for tumor recurrence and survival of HCC patients. Results: CCL20 expression was verified in all tumor specimens. CCL20 expression was associated with tumor size ( P = 0.002), tumor number ( P = 0.031), vascular invasion ( P = 0.003), tumor differentiation ( P = 0.024), and tumor recurrence ( P < 0.001). Patients with high CCL20 expression had poorer recurrence-free survival and overall survival (both P < 0.001) than those with low CCL20 expression. Multivariate analysis showed CCL20 expression was an independent predictor of tumor recurrence (Hazard ratio 3.934, P = 0.002), recurrence-free survival (Hazard ratio 2.573, P = 0.001), and overall survival (Hazard ratio 2.930, P = 0.001). Conclusion: CCL20 expression was associated with tumor recurrence and survival of HCC patients. It may be used to predict prognosis of patients with HCC and may be a new target of postoperative adjuvant therapy.


Related Articles

  • Prognostic Variables for Cancer-Related Survival in Node-Negative Colorectal Carcinomas. F. Di Fabio; R. Nascimbeni; V. Villanacci; C. Baronchelli; D. Bianchi; G. Fabbretti; C. Casella; B. Salerni // Digestive Surgery;2004, Vol. 21 Issue 2, p128 

    Background/Aim: The efficacy of adjuvant treatment in node-negative colorectal carcinoma is unproven. The purpose of this study was to analyze the prognostic value of routinely detectable clinicopathological variables in order to identify subgroups of node-negative colorectal cancer patients at...

  • Well-Differentiated Neuroendocrine Neoplasia: Relapse-Free Survival and Predictors of Recurrence after Curative Intended Resections. Dieckhoff, P.; Runkel, H.; Daniel, H.; Wiese, D.; Koenig, a.; Fendrich, V.; Bartsch, D.K.; Moll, R.; Müller, D.; arnold, R.; Gress, T.; Rinke, a. // Digestion;Oct2014, Vol. 90 Issue 2, p89 

    Background: Resection with curative intention is the cornerstone of treatment in patients with neuroendocrine tumors. A proportion of patients will relapse after R0 resection, but the factors predictive of recurrence are not well understood. Methods: A database established 1998 at the University...

  • HIFU as a Neoadjuvant Therapy in Cancer Treatment. Zhong, P.; Xing, F.; Huang, X.; Zhu, H.; Lo, H. W.; Zhong, X.; Pruitt, S.; Robertson, C. // AIP Conference Proceedings;2011, Vol. 1359 Issue 1, p289 

    To broaden the application spectrum of HIFU in cancer therapy, we performed a pilot experiment to evaluate the potential of using HIFU as a neoadjuvant therapy prior to surgery. Mice bearing wild-type B16F10 melanoma inoculated subcutaneously were either untreated (control) or treated by HIFU,...

  • The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas. Ahn, Sung; Kim, Sung; Jeon, Tae; Cho, Ho; Choi, Sae; Yun, Mi; Lee, Jong; Kim, Kyung; Ahn, Sung Gwe; Kim, Sung Hoon; Jeon, Tae Joo; Cho, Ho Jin; Choi, Sae Byeol; Yun, Mi Jin; Lee, Jong Doo; Kim, Kyung Sik // Journal of Gastrointestinal Surgery;Nov2011, Vol. 15 Issue 11, p2044 

    Purpose: (18)F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) scan reflects tumor differentiation and predicts clinical outcome in patients with hepatocellular carcinoma (HCC). We investigated the correlation of PET scans with tumor differentiation and early...

  • Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases. Wang, Yao; Yu, Mei; Yang, Jia-Xin; Cao, Dong-Yan; Shen, Keng; Lang, Jing-He // Cancer Management & Research;Oct2018, Vol. 10, p4915 

    No abstract available.

  • Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study. Diessner, Joachim; Wischnewsky, Manfred; Blettner, Maria; Häusler, Sebastian; Janni, Wolfgang; Kreienberg, Rolf; Stein, Roland; Stüber, Tanja; Schwentner, Lukas; Bartmann, Catharina; Wöckel, Achim // PLoS ONE;12/19/2016, Vol. 11 Issue 12, p1 

    Background: Luminal A breast cancers respond well to anti-hormonal therapy (HT), are associated with a generally favorable prognosis and constitute the majority of breast cancer subtypes. HT is the mainstay of treatment of these patients, accompanied by an acceptable profile of side effects,...

  • Four differentially methylated gene pairs to predict the prognosis for early stage hepatocellular carcinoma patients. Liu, Shaoguang; Miao, Changfeng; Liu, Juan; Wang, Chang-Cheng; Lu, Xiao-Jie // Journal of Cellular Physiology;Sep2018, Vol. 233 Issue 9, p6583 

    Hepatocellular carcinoma (HCC) was the second most common malignant tumor with a poor prognostic condition. We aimed to identify novel methylation signatures to predict HCC patients at their early stages. Differentially expressed methylated genes between HCC patients and normal liver tissues...

  • Liver metastases from esophageal carcinoma: is there a role for surgical resection? Huddy, J. R.; Thomas, R. L.; Worthington, T. R.; Karanjia, N. D. // Diseases of the Esophagus;Jul2015, Vol. 28 Issue 5, p483 

    Esophageal cancer recurrence rates after esophagectomy are high, and locally recurrent or distant metastatic disease has poor prognosis. Management is limited to palliative chemotherapy and symptomatic interventions. We report our experience of four patients who have undergone successful liver...

  • Multivariate and Univariate Analysis of Prognostic Factors following Resection in HCC: The Birmingham Experience. John, Abraham R.; Khan, Saboor; Mirza, Darius F.; Mayer, A. David; Buckels, John A. C.; Bramhall, Simon R. // Digestive Surgery;2006, Vol. 23 Issue 1/2, p103 

    Background: The aim of this study was to look into our experience of resection for hepatocellular carcinomas (HCCs) in a tertiary Hepatobiliary and Liver Transplant Unit in the UK. Methods: A retrospective analysis of our prospective database was carried out. Results: 715 cases of HCC were seen....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics